The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and…
Read More
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly: study
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October…
Read More
NIH Launches Trial of Antibody Drugs Against COVID-19
WEDNESDAY, Oct. 14, 2020 — A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH). The research will…
Read More
Study shows similar antibody response to key SARS-CoV-2 ‘spike’ protein in COVID-19
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that antibody responses to SARS-CoV-2 are similar in COVID-19 patients with and without diabetes, and thus are unlikely to be responsible for the…
Read More
COVID-19 antibody studies across Brazil reveal Amazon region badly affected
Two nationwide COVID-19 antibody seroprevalence studies from Brazil show that many cities along the Amazon were hit hardest at the beginning of the epidemic in May and June, along with poorer and Indigenous communities. The research is presented at this…
Read More
Antibody study suggests herd immunity to COVID-19 is 'unachievable'
Coronavirus herd immunity may be ‘unachievable’: Only 5% of people in Spain developed antibodies three months after the pandemic peaked, study suggests Researchers looked at blood test results of a nationwide sample of more than 61,000 participants in Spain Around 5%…
Read More
ONE-THIRD of coronavirus antibody tests may return false negatives
Up to ONE-THIRD of all coronavirus antibody tests may come back as false negatives, study finds Researchers looked at 40 studies analyzing coronavirus antibody tests, which determine if someone has previously been infected Sensitivity rates, meaning the rate at which tests…
Read More
Scientists developing COVID-19 antibody treatment from cow's blood
Are COWS the key to treating coronavirus? Human trial of an antibody treatment made from bovine blood is set to start next month SAb Biotherapeutics, based in Sioux Falls, South Dakota, have genetically engineered cows to give them part-human immune systems…
Read More
Early antibody testing suggests COVID-19 infections in L.A. County greatly exceed documented cases
USC and the Los Angeles County Department of Public Health on Monday released preliminary results from a collaborative scientific study that suggests infections from the new coronavirus are far more widespread—and the fatality rate much lower—in L.A. County than previously…
Read More